Treat to target strategy in early rheumatoid arthritis versus routine care – A comparative clinical practice study

Treat to target strategy in early rheumatoid arthritis versus routine care – A comparative clinical practice study

To assess the 2-year effect on disease activity and health-related quality of life (HRQoL) of implementing a clinical practice treat-to-target (T2T) strategy in patients with rheumatoid arthritis (RA). Patients in the Norwegian Very Early Arthritis Cohort 2.0 (NOR-VEAC 2.0), included 2010–2015, were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in arthritis and rheumatism 2019-04, Vol.48 (5), p.808-814
Hauptverfasser: Brinkmann, Gina Hetland, Norvang, Vibeke, Norli, Ellen Sauar, Grøvle, Lars, Haugen, Anne Julsrud, Lexberg, Åse Stavland, Rødevand, Erik, Bakland, Gunnstein, Nygaard, Halvor, Krøll, Frode, Widding-Hansen, Inger Johanne, Bjørneboe, Olav, Thunem, Cathrine, Kvien, Tore, Mjaavatten, Maria Dahl, Lie, Elisabeth
Format: Artikel
Sprache:eng
Schlagworte:
Antirheumatic agents
Prognosis
Rheumatoid arthritis
Treatment outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To assess the 2-year effect on disease activity and health-related quality of life (HRQoL) of implementing a clinical practice treat-to-target (T2T) strategy in patients with rheumatoid arthritis (RA). Patients in the Norwegian Very Early Arthritis Cohort 2.0 (NOR-VEAC 2.0), included 2010–2015, were treated according to T2T principles with visits at baseline, 3, 6, 9, 12 months, then every 6 months plus monthly visits until DAS28 
ISSN:0049-0172
1532-866X
DOI:10.1016/j.semarthrit.2018.07.004